PPARG: A Promising Therapeutic Target in Breast Cancer and Regulation by Natural Drugs

Figure 2

PPARG expression levels in BC patients in relation to clinicopathological characteristics. Each column represents a feature variable, with varying colors denoting different subtypes or stages, and the lines depicting the distribution of the same sample across the distinct feature variables. (a) PPARG expression level was related to pT-stage and pTNM-stage BC. (b) PPARG expression levels correlated with survival status, age, and pT-stage of ER+ BC.

(a)

(b)